Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Tafani, Marco ^a   Di Vito, Maura ^a   Frati, Alessandro ^b   Pellegrini, Laura ^a   De Santis, Elena ^c   Sette, Giovanni ^d   Eramo, Adriana ^d   Sale, Patrizio ^e   Mari, Emanuela ^a   Santoro, Antonio ^c   Raco, Antonino ^c   Salvati, Maurizio ^b   De Maria, Ruggero ^d   Russo, Matteo A ^a,e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; HIF1A PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; COX2 GENE; DOWN REGULATION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIC CELL; NOS2 GENE; P2X7R GENE; PROTEIN LOCALIZATION; PTX3 GENE; RAGE GENE; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING; BRAIN; BRAIN MAPPING; BRAIN TUMOR; CANCER INVASION; CANCER STEM CELL; CELL HYPOXIA; CELL MOTION; GENE EXPRESSION; GENETICS; HISTOLOGY; INFLAMMATION; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE;

BRAIN; BRAIN MAPPING; BRAIN NEOPLASMS; CELL HYPOXIA; CELL MOVEMENT; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; NF-KAPPA B; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 79953865922     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-32     Document Type: Article

References (34)

1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008, 359:492-507. 10.1056/NEJMra0708126, 18669428.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, . European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352:987-996. 10.1056/NEJMoa043330, 15758009, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group.
3. Clarke J, Butowski N, Chang S. Recent Advances in Therapy for Glioblastoma. Arch Neurol 2010, 67:279-283. 10.1001/archneurol.2010.5, 20212224.
4. Takeuchi H, Hashimoto N, Kitai R, Kubota T, Kikuta K. Proliferation of vascular smooth muscle cells in glioblastoma multiforme. J Neurosurg 2010, 113:218-224. 10.3171/2009.10.JNS08631, 19929197.
5. Borovski T, Verhoeff JJ, ten Cate R, Cameron K, de Vries NA, van Tellingen O, Richel DJ, van Furth WR, Medema JP, Sprick MR. Tumor microvasculature supports proliferation and expansion of glioma-propagating cells. Int J Cancer 2009, 125:1222-1230. 10.1002/ijc.24408, 19431144.
6. Pouysségur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443.
7. Yeoa EJ, Chunb YS, Park JW. New anticancer strategies targeting HIF-1. Biochem Pharm 2004, 68:1061-1069. 10.1016/j.bcp.2004.02.040, 15313402.
8. Mobasheri A, Richardson S, Mobasheri R, Shakibaei M, Hoyland JA. Hypoxia inducible factor-1 and facilitative glucose transporters GLUT1 and GLUT3: putative molecular components of the oxygen and glucose sensing apparatus in articular chondrocytes. Histol Histopathol 2005, 20:1327-1338.
9. Cummins EP, Taylor CT. Hypoxia-responsive transcription factors. Pflugers Arch 2005, 450:363-371. 10.1007/s00424-005-1413-7, 16007431.
10. Ravenna L, Sale P, Di Vito M, Russo A, Salvatori L, Tafani M, Mari E, Sentinelli S, Petrangeli E, Gallucci M, Di Silverio F, Russo MA. Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma. Prostate 2009, 69:1245-1255. 10.1002/pros.20966, 19444819.
11. Tafani M, Russo A, Di Vito M, Sale P, Pellegrini L, Schito L, Gentileschi S, Bracaglia R, Marandino F, Garaci E, Russo MA. Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment. Cancer Sci 2010, 4:1014-23.
12. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F, Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004, 64:7011-7021. 10.1158/0008-5472.CAN-04-1364, 15466194.
13. Singh SK, Clarke ID, Hide T, Dirks PB. Cancer stem cells in nervous system tumors. Oncogene 2004, 23:7267-7273. 10.1038/sj.onc.1207946, 15378086.
14. Pérez Castillo A, Aguilar-Morante D, Morales-García JA, Dorado J. Cancer stem cells and brain tumors. Clin Transl Oncol 2008, 10:262-267.
15. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401. 10.1038/nature03128, 15549107.
16. Eramo A, Ricci-Vitiani L, Zeuner A, Pallini R, Lotti F, Sette G, Pilozzi E, Larocca LM, Peschle C, De Maria R. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006, 13:1238-1241. 10.1038/sj.cdd.4401872, 16456578.
17. Tafani M, Schito L, Anwar T, Indelicato M, Sale P, Di Vito M, Morgante E, Beraldi R, Makovec F, Letari O, Caselli G, Spadafora C, Pucci B, Russo MA. Induction of autophagic cell death by a novel molecule is increased by hypoxia. Autophagy 2008, 4:1042-1053.
18. Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010, 16:2927-2931. 10.1158/1078-0432.CCR-09-2329, 20484021.
19. do Carmo A, Patricio I, Cruz MT, Carvalheiro H, Oliveira CR, Lopes MC. CXCL12/CXCR4 promotes motility and proliferation of glioma cells. Cancer Biol Ther 2010, 9:56-65. 10.4161/cbt.9.1.10342, 19923906.
20. Brat DJ, Mapstone TB. Malignant glioma physiology, cellular response to hypoxia and its role in tumor progression. Ann Intern Med 2003, 138:659-668.
21. Taylor CT, Cummins EP. The role of NF-kappaB in hypoxia-induced gene expression. Ann N Y Acad Sci 2009, 1177:178-184. 10.1111/j.1749-6632.2009.05024.x, 19845620.
22. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453:807-811. 10.1038/nature06905, 2669289, 18432192.
23. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, Sobolewski A, Condliffe AM, Cowburn AS, Johnson N, Chilvers ER. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha dependent NF-kappaB activity. J Exp Med 2005, 201:105-115. 10.1084/jem.20040624, 2212759, 15630139.
24. Kostova N, Zlateva S, Ugrinova I, Pasheva E. The expression of HMGB1 protein and its receptor RAGE in human malignant tumors. Mol Cell Biochem 2010, 337:251-258. 10.1007/s11010-009-0305-0, 19876719.
25. Tateno T, Ueno S, Hiwatashi K, Matsumoto M, Okumura H, Setoyama T, Uchikado Y, Sakoda M, Kubo F, Ishigami S, Shinchi H, Natsugoe S. Expression of receptor for advanced glycation end products (RAGE) is related to prognosis in patients with esophageal squamous cell carcinoma. Ann Surg Oncol 2009, 16:440-446. 10.1245/s10434-008-0237-z, 19023628.
26. Bassi R, Giussani P, Anelli V, Colleoni T, Pedrazzi M, Patrone M, Viani P, Sparatore B, Melloni E, Riboni L. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. J Neurooncol 2008, 87:23-33. 10.1007/s11060-007-9488-y, 17975708.
27. Braganhol E, Huppes D, Bernardi A, Wink MR, Lenz G, Battastini AM. A comparative study of ectonucleotidase and P2 receptor mRNA profiles in C6 cell line cultures and C6 ex vivo glioma model. Cell Tissue Res 2009, 335:331-340. 10.1007/s00441-008-0723-4, 19023597.
28. Wei W, Ryu JK, Choi HB, McLarnon JG. Expression and function of the P2X(7) receptor in rat C6 glioma cells. Cancer Lett 2008, 260:79-87. 10.1016/j.canlet.2007.10.025, 18039556.
29. Tamajusuku AS, Villodre ES, Paulus R, Coutinho-Silva R, Battasstini AM, Wink MR, Lenz G. Characterization of ATP-induced cell death in the GL261 mouse glioma. J Cell Biochem 2010, 109:983-991. 10.1002/jcb.22478, 20069573.
30. Di Virgilio F, Ferrari D, Adinolfi E. P2X(7): a growth-promoting receptor-implications for cancer. Purinergic Signal 2009, 5:251-256. 10.1007/s11302-009-9145-3, 2686832, 19263244.
31. Adinolfi E, Callegari MG, Cirillo M, Pinton P, Giorgi C, Cavagna D, Rizzuto R, Di Virgilio F. Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis. J Biol Chem 2009, 284:10120-10128. 10.1074/jbc.M805805200, 2665066, 19204004.
32. Morrone FB, Horn AP, Stella J, Spiller F, Sarkis JJ, Salbego CG, Lenz G, Battastini AM. Increased resistance of glioma cell lines to extracellular ATP cytotoxicity. J Neurooncol 2005, 71:135-140. 10.1007/s11060-004-1383-1, 15690128.
33. Hara A, Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 2004, 108:43-48. 10.1007/s00401-004-0860-0, 15088099.
34. Deban L, Bottazzi B, Garlanda C, de la Torre YM, Mantovani A. Pentraxins: Multifunctional proteins at the interface of innate immunity and inflammation. Biofactors 2009, 35:138-145. 10.1002/biof.21, 19449441.